Recent work has pointed out a central role of the muscle-specific E3 ubiquitin ligase mitsugumin 53 (MG53; also called TRIM72) in promoting ubiquitin-dependent IR and IRS-1 degradation, which is associated with reduced IR signaling, insulin resistance, and metabolic disorders (52). Here, TRIM72 is linked to metabolic disease.